Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?

• Published in: Journal of Dermatological Treatment Vol. 33; no. 5; pp. 2674 - 2676
• Main Authors: Giza, Agnieszka, Gałązka, Krystyna, Jońca, Marcin, Raźny, Małgorzata, Zimowska-Curyło, Dagmara, Wilk, Mateusz, Goldman-Mazur, Sarah, Piątkowska-Jakubas, Beata, Sacha, Tomasz
• Format: Report
• Language: English
• Published: Taylor & Francis 04.07.2022
• Subjects: Cutaneous T cell lymphoma; hemophagocytic syndrome; high dose chemotherapy; subcutaneous panniculitis-like T-cell lymphoma
• ISSN: 0954-6634; 1471-1753
• DOI: 10.1080/09546634.2020.1809624

Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare, cutaneous lymphoma involving subcutaneous adipose tissue. SPTL is associated in less than 20% with hemophagocytic syndrome (HPS). A 5-year overall survival rate is inferior in patients with SPTL and HPS (46%) as compared with 91% in patients without HPS. No standardized therapy for SPTCL has yet been established. This is a case of 35-year-old Caucasian man with a one-month history of B symptoms with the suspicion of Still's disease, at admission with leucopenia, high LDH, ferritin, sIl-R2, and triglycerides levels, hepatosplenomegaly, small right supraclavicular nodule, and irregular thickening of trunk subcutaneous tissue. The abdomen MRI showed generalized thickening of mesentery and colonic mucosa. In the patient, diagnosis of SPTCL was established with secondary HPS. CHOEP chemotherapy and modified HLH 2014 protocol were applied with subsequent high dose chemotherapy (BEAM) supported by autologous stem cells transplantation. Treatment was complicated by pancytopenia and pneumonia. The outcome of the disease treated by intensive protocol seems to be good.